Gut microbial metabolites lower 24-hour systolic blood pressure in untreated essential hypertensive patients
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
16S rRNA sequencing from a phase II randomized placebo-controlled double-blind cross-over trial using SCFA-supplementation delivered as HAMSAB (acetylated and butyrylated high amylose maize starch) in hypertensive participants.
创建时间：
2022-11-21
